Risk and benefit for targeted therapy agents in paediatric phase I trials in oncology - a systematic review and metaanalysis protocol
Favorite
Share
More Options
5

Open in WPS to view all 5 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
